Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $1.15 Million - $1.31 Million
-3,886 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $140,344 - $174,412
-598 Reduced 13.34%
3,886 $1.11 Million
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $33,277 - $41,297
148 Added 3.41%
4,484 $1.24 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $960,857 - $1.18 Million
4,336 New
4,336 $1 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $498,610 - $576,733
-3,410 Closed
0 $0
Q2 2020

Aug 06, 2020

BUY
$136.42 - $164.18 $6,411 - $7,716
47 Added 1.4%
3,410 $560,000
Q1 2020

May 12, 2020

SELL
$119.05 - $147.35 $5,357 - $6,630
-45 Reduced 1.32%
3,363 $467,000
Q4 2019

Jan 31, 2020

SELL
$106.92 - $132.43 $37,422 - $46,350
-350 Reduced 9.31%
3,408 $448,000
Q3 2019

Nov 08, 2019

BUY
$106.79 - $116.16 $401,316 - $436,529
3,758 New
3,758 $420,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Meristem Family Wealth, LLC Portfolio

Follow Meristem Family Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meristem Family Wealth, LLC with notifications on news.